Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Open in API
Filings indexed 1,586 across all filing types
Latest filing 2015-07-01 Director's Dealing
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
3 Filing
Director's Dealing
2015-07-01 English
3 Filing
Director's Dealing
2015-07-01 English
3 Filing
Director's Dealing
2015-07-01 English
3 Filing
Director's Dealing
2015-07-01 English
S-1/A Filing
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 5 to Form S-1 Registration Statement filed with the SEC by Natera, Inc. It includes detailed information about securities registration, indemnification of directors and officers, recent sales of unregistered securities, and related legal and financial disclosures. The Form S-1 is a registration statement used for initial public offerings or other securities offerings under the Securities Act of 1933. This document is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a transcript, presentation, or voting announcement. It is a regulatory filing related to securities registration and compliance. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (15,000 characters) and content confirm it is a substantive filing, not a brief announcement or certification.
2015-06-30 English
S-1/A Filing
Capital/Financing Update Classification · 95% confidence The document is titled 'Amendment No. 4 to Form S-1 Registration Statement Under The Securities Act of 1933' filed with the SEC. It is a registration statement related to an initial public offering (IPO) of common stock by Natera, Inc. The text includes prospectus summary, risk factors, use of proceeds, capitalization, dilution, selected financial data, management's discussion and analysis, business description, management, executive compensation, principal stockholders, description of capital stock, underwriting, legal matters, and financial statements index. This is a typical structure of a registration statement prospectus for an IPO, which is a capital raising document. The document is not an earnings release, annual report, or any other report type but a capital/financing update related to the offering of new shares to the public. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 15,000 characters, indicating it is a full filing, not just an announcement or certification.
2015-06-29 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.